Shane D Ashbaugh, PA
Physician Assistant · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 3
- Since medical school
- 6 years
- Graduated 2020
Offices
3 locations · Washington Township Medical Foundation · 125 clinicians in this group
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Shane D Ashbaugh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$24,917
Medicare paid this office $24,917 for 106 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 51 | $5,208 | $69 |
| Aspiration and/or injection of fluid from large joint | 32 | $4,349 | $60 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 18 | $3,459 | None |
| Replacement of knee joint, both sides of knee | 16 | $2,619 | $154 |
| Return visit (30+ min) | 18 | $1,895 | $95 |
See all 9 services
| Short return visit (20+ min) | 51 | $5,208 | $69 |
| Aspiration and/or injection of fluid from large joint | 32 | $4,349 | $60 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 18 | $3,459 | None |
| Replacement of knee joint, both sides of knee | 16 | $2,619 | $154 |
| Return visit (30+ min) | 18 | $1,895 | $95 |
| X-ray of knee, 4 or more views | 13 | $735 | $25 |
| X-ray of shoulder, minimum of 2 views | 16 | $717 | $18 |
| X-ray of knee, 3 views | 14 | $554 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $107 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 29 | More than 63% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 14 | More than 53% of doctors who do this |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | – | 49 | 50 | 74 | 72 |
| Replacement of knee joint, both sides of knee | – | 15 | 18 | 15 | 17 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
106 Original Medicare patients in 2024. Average age 76 · Women 68% · Also on Medicaid 27% · Health risk score 1.03. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 34% · Coronary heart disease 34% · Chronic kidney disease 23% · Heart failure 20% · Depression 18% · Cancer 16% · Atrial fibrillation 12% · COPD 10%.
The office billed $100,301, Medicare allowed $32,379 and paid $24,917; for 586 services of 30 kinds; $3,567 of it was for drugs given in the office and $21,350 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 106 | 586 | 76 | 1.03 | $100,301 | $24,917 |
| 2023 | 165 | 674 | 75 | 0.91 | $108,958 | $30,413 |
| 2022 | 150 | 453 | 75 | 1.07 | $91,159 | $25,712 |
| 2021 | 199 | 687 | 76 | 1.15 | $134,320 | $44,649 |
| 2020 | 39 | 78 | 75 | 1.16 | $13,684 | $4,557 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 68 | $5,767 | $69 |
| Aspiration and/or injection of fluid from large joint | 40 | $4,472 | $60 |
| New patient visit (30+ min) | 47 | $4,139 | $88 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 24 | $4,113 | None |
| Replacement of knee joint, both sides of knee | 15 | $2,211 | $147 |
| Return visit (30+ min) | 16 | $1,646 | $91 |
| X-ray of knee, 4 or more views | 18 | $1,195 | $24 |
| X-ray of knee, 3 views | 16 | $712 | $20 |
| X-ray of shoulder, minimum of 2 views | 12 | $523 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $97 | None |
2022: 9 services
| Return visit (30+ min) | 45 | $4,935 | $93 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 19 | $3,363 | None |
| Aspiration and/or injection of fluid from large joint | 30 | $2,984 | $60 |
| Replacement of knee joint, both sides of knee | 17 | $2,675 | $149 |
| Short return visit (20+ min) | 31 | $2,496 | $67 |
| Long return visit (40+ min) | 20 | $2,257 | $113 |
| New patient visit (30+ min) | 19 | $1,510 | $79 |
| X-ray of knee, 3 views | 12 | $608 | $22 |
| X-ray of knee, 4 or more views | 11 | $524 | $29 |
2021: 13 services
| Return visit (30+ min) | 71 | $8,595 | $94 |
| Long return visit (40+ min) | 42 | $7,241 | $137 |
| New patient visit (45+ min) | 29 | $3,541 | $122 |
| Short return visit (20+ min) | 43 | $3,516 | $70 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $3,024 | None |
| Aspiration and/or injection of fluid from large joint | 25 | $2,694 | $55 |
| Replacement of knee joint, both sides of knee | 14 | $2,391 | $159 |
| New patient visit (30+ min) | 27 | $2,344 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $1,920 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,669 | $104 |
| X-ray of knee, 3 views | 19 | $882 | $25 |
| X-ray of shoulder, minimum of 2 views | 17 | $774 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $86 | None |
2020: 1 service
| New patient visit (30+ min) | 13 | $1,132 | $87 |
Drugs they prescribed that Part D paid
$4,349
Pharmacies billed $4,349 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 23% of their Part D prescriptions (99 of 438) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
437 generic and fewer than 11 brand-name prescriptions · $4,349 in drug cost · 67 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 39 | $993 | $25 |
| Ondansetron Odt | 80 | $695 | $9 |
| Hydrocodone-Acetaminophen | 69 | $674 | $10 |
| Gabapentin | 67 | $673 | $10 |
| Pantoprazole | 33 | $311 | $9 |
See all 10 drugs
| Celecoxib | 39 | $993 | $25 |
| Ondansetron Odt | 80 | $695 | $9 |
| Hydrocodone-Acetaminophen | 69 | $674 | $10 |
| Gabapentin | 67 | $673 | $10 |
| Pantoprazole | 33 | $311 | $9 |
| Cephalexin | 24 | $186 | $8 |
| Oxycodone-Acetaminophen | 12 | $104 | $9 |
| Meloxicam | 23 | $62 | $3 |
| Amoxicillin | 33 | $50 | $2 |
| Tramadol | 14 | $37 | $3 |
Year by year
| 2024 | 438 | 120 | 23% (99) | None | $4,349 |
| 2023 | 417 | 130 | 15% (63) | 0% | $7,947 |
| 2022 | 373 | 120 | 18% (68) | None | $10,127 |
| 2021 | 405 | 124 | 20% (79) | None | $8,889 |
| 2020 | 72 | 28 | 24% (17) | None | $1,626 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Gabapentin | 102 | $2,170 | $21 |
| Diclofenac | 31 | $2,138 | $69 |
| Celecoxib | 38 | $783 | $21 |
| Duloxetine | 14 | $664 | $47 |
| Hydrocodone-Acetaminophen | 42 | $452 | $11 |
| Ondansetron Odt | 42 | $395 | $9 |
| Cephalexin | 17 | $313 | $18 |
| Pantoprazole | 18 | $174 | $10 |
| Oxycodone-Acetaminophen | 15 | $87 | $6 |
| Meloxicam | 24 | $66 | $3 |
| Amoxicillin | 15 | $20 | $1 |
2022: 11 drugs
| Gabapentin | 102 | $2,505 | $25 |
| Duloxetine | 33 | $2,323 | $70 |
| Pregabalin | 25 | $2,170 | $87 |
| Diclofenac | 27 | $1,257 | $47 |
| Hydrocodone-Acetaminophen | 46 | $534 | $12 |
| Ondansetron Odt | 40 | $430 | $11 |
| Celecoxib | 11 | $245 | $22 |
| Pantoprazole | 16 | $203 | $13 |
| Oxycodone | 16 | $116 | $7 |
| Cephalexin | 11 | $88 | $8 |
| Amoxicillin | 19 | $19 | $1 |
2021: 8 drugs
| Gabapentin | 115 | $2,907 | $25 |
| Pregabalin | 29 | $1,883 | $65 |
| Diclofenac | 32 | $1,095 | $34 |
| Duloxetine | 40 | $864 | $22 |
| Hydrocodone-Acetaminophen | 41 | $667 | $16 |
| Ondansetron Odt | 38 | $431 | $11 |
| Oxycodone | 32 | $257 | $8 |
| Cephalexin | 12 | $73 | $6 |
2020: 1 drug
| Gabapentin | 14 | $208 | $15 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1821635467
- Licence
- CA 58356
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, surgical (363AS0400X); Federal specialty code 246ZC0007X (246ZC0007X); Federal specialty code 246ZX2200X (246ZX2200X)
- Mailing address
- 38690 Stivers St Ste A, Fremont, CA, 94536
- NPI first listed
- 2019-12-03
- NPI last updated
- 2020-07-29
- NPI record certified
- 2020-07-29
This is when the NPI record was last certified, not a medical board exam.